Eyecelerator, a partner of the American Academy of Ophthalmology, is self-described as having the goal of advancing eye care ...
Preoperative identification and eradication of Demodex can improve ocular-surface comfort and may mitigate cataract-surgery ...
Oculis Holding AG announced that the final patient visit has been completed in the DIAMOND phase 3 program assessing OCS-01, ...
Propensity-matched analyses showed smokers had significantly higher risk across all studied ocular outcomes over 10 years, ...
Christopher E. Starr, MD, FACS, highlights diagnostic gaps in dry eye, emphasizing neuropathic corneal pain and reviewing ...
Self-reported hearing impairment reduced the likelihood of achieving clinically meaningful functional improvement after ...
New 52-week analyses from the phase 3 SOL-1 trial suggest that the investigational intravitreal therapy AXPAXLI (OTX-TKI) may ...
Glaukos Corporation announced that the US Centers for Medicare and Medicaid Services (CMS) has assigned a permanent ...
Prospective multicenter open-label first-in-human cohort enrolled 10 cataract patients (14 eyes), age 60–87, with 36-month follow-up after phacoemulsification and OmniVu implantation. Refractive ...
An analysis of lifitegrast trial subgroups showed that earlier treatment and milder baseline disease were associated with faster and greater symptom improvement. The management of dry eye disease may ...
Michaelides is professor at UCL Institute of Ophthalmology and Moorfields Eye Hospital, London.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results